Author(s) Sugama J, Sanada H, Shigeta Y, Nakagami G, Konya C, et al.

Journal BMC geriatrics. Date of publication 2012 May 29;volume 12():22.

Abstract 1. BMC Geriatr. 2012 May 29;12:22. doi: 10.1186/1471-2318-12-22. Efficacy of an improved absorbent pad on incontinence-associated dermatitis in older women: cluster randomized controlled trial. Sugama J(1), Sanada H, Shigeta Y, Nakagami G, Konya C. Author information: (1)Department of Clinical Nursing, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Ishikawa, Japan. junkosgm@mhs.mp.kanazawa-u.ac.jp Comment in J Urol. 2013 May;189(5):1819-20. doi: 10.1016/j.juro.2013.02.052. BACKGROUND: Most older adults with urinary incontinence use absorbent pads. Because of exposure to moisture and chemical irritating substances in urine, the perineal skin region is always at risk for development of incontinence-associated dermatitis (IAD). The aim of this study was to examine the efficacy of an improved absorbent pad against IAD. METHODS: A cluster randomized controlled design was used to compare the efficacy of two absorbent pads. Female inpatients aged ≥65 years who had IAD and used an absorbent pad or diaper all day were enrolled. Healing rate of IAD and variables of skin barrier function such as skin pH and skin moisture were compared between the usual absorbent pad group (n = 30) and the test absorbent pad group (n = 30). RESULTS: Thirteen patients (43.3%) from the test absorbent pad group and 4 patients (13.3%) from the usual absorbent pad group recovered completely from IAD. Moreover, the test absorbent pad group healed significantly faster than the usual absorbent pad group (p = 0.009). On the other hand, there were no significant differences between the two groups in skin barrier function. CONCLUSION: The test absorbent pad for older adults with urinary incontinence might be more efficacious against IAD than usual absorbent pad. TRIAL REGISTRATION: UMIN-CTR: UMIN000006188. DOI: 10.1186/1471-2318-12-22 PMCID: PMC3426468 PMID: 22642800 [Indexed for MEDLINE]

Source ID (e.g. PMID): 22642800